10 Results for "

JNK2/3-IN-1

" in MedChemExpress (MCE) Product Catalog:
Products (10)

10 Results for "JNK2/3-IN-1" in MCE Product Catalog:

Cat. No.: HY-176213
Target:  

JNK

Research Areas:  

Neurological Disease

JNK2/3-IN-1 (Compound 56d) is an irreversible covalent inhibitor of c-Jun N-terminal kinases 2/3 (JNK2/3) with IC50 values of 830 and 1909 nM, respectively. JNK2/3-IN-1 is promising for research of neurodegenerative diseases (e.g., Parkinson’s, Alzheimer’s) and fibrotic disorders .
loading...
    loading...
59
59 Publications Verification
Cat. No.: HY-13319
CAS No.: 1410880-22-6
Purity:  99.67%
Synonyms: JNK INhibitor XVI
Target:  

JNK

Research Areas:  

Cancer

JNK-IN-8 (JNK Inhibitor XVI) is a potent JNK inhibitor with IC50s of 4.7 nM, 18.7 nM, and 1 nM for JNK1, JNK2, and JNK3, respectively .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-107600
CAS No.: 312538-03-7
Purity:  99.38%
Target:  

JNK

Research Areas:  

Inflammation/Immunology

IQ-3 is a specific inhibitor of the c-Jun N-terminal kinase (JNK) family, with preference for JNK3. IQ-3 exhibits Kd values of 0.24 μM, 0.29 μM and 0.066 μM for JNK1, JNK2 and JNK3, respectively .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-100233
CAS No.: 23146-22-7
Purity:  99.28%
Target:  

JNK

Research Areas:  

Inflammation/Immunology Cancer

IQ-1S free acid is a prospective inhibitor of NF-κB/activating protein 1 (AP-1) activity with an IC50 of 2.3±0.41 μM. IQ-1S free acid has binding affinity (Kd values) in the nanomolar range for all three JNKs with Kds of 100 nM, 240 nM, and 360 nM for JNK3, JNK1, and JNK2, respectively.
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-N7394A
CAS No.: 84709-25-1
Synonyms: D-EpigalbacIN
(-)-Zuonin A (D-Epigalbacin), a naturally occurring lignin, is a potent, selective JNKs inhibitor, with IC50s of 1.7 μM, 2.9 μM and 1.74 μM for JNK1, JNK2 and JNK3, respectively .
loading...
    loading...
Cat. No.: HY-13319G
CAS No.: 1410880-22-6
Synonyms: JNK INhibitor XVI (GMP)
JNK-IN-8 (JNK Inhibitor XVI) (GMP) is JNK-IN-8 (HY-13319) produced by using GMP guidelines. GMP small molecules work appropriately as an auxiliary reagent for cell therapy manufacture. JNK-IN-8 is a potent JNK inhibitor with IC50s of 4.7 nM, 18.7 nM, and 1 nM for JNK1, JNK2, and JNK3, respectively .
loading...
    loading...
Cat. No.: HY-13319R
CAS No.: 1410880-22-6
Synonyms: JNK INhibitor XVI (Standard)
Target:  

Reference Standards JNK

Research Areas:  

Cancer

JNK-IN-8 (Standard) is the analytical standard of JNK-IN-8 (HY-13319). This product is intended for research and analytical applications. JNK-IN-8 (JNK Inhibitor XVI) is a potent JNK inhibitor with IC50s of 4.7 nM, 18.7 nM, and 1 nM for JNK1, JNK2, and JNK3, respectively .
loading...
    loading...
Cat. No.: HY-107600R
CAS No.: 312538-03-7
Target:  

Reference Standards JNK

Research Areas:  

Inflammation/Immunology

IQ-3 (Standard) is the analytical standard of IQ-3 (HY-107600). This product is intended for research and analytical applications. IQ-3 is a specific inhibitor of the c-Jun N-terminal Kinase (JNK) family, with preference for JNK3. IQ-3 exhibits Kd values of 0.24 μM, 0.29 μM and 0.066 μM for JNK1, JNK2 and JNK3, respectively .
loading...
    loading...
Cat. No.: HY-100233R
CAS No.: 23146-22-7
Target:  

JNK Reference Standards

Research Areas:  

Inflammation/Immunology Cancer

IQ-1S (free acid) (Standard) is the analytical standard of IQ-1S (free acid) (HY-100233). This product is intended for research and analytical applications. IQ-1S free acid is a prospective inhibitor of NF-κB/activating protein 1 (AP-1) activity with an IC50 of 2.3±0.41 μM. IQ-1S free acid has binding affinity (Kd values) in the nanomolar range for all three JNKs with Kds of 100 nM, 240 nM, and 360 nM for JNK3, JNK1, and JNK2, respectively.
loading...
    loading...
Cat. No.: HY-184652
Target:  

LRRK2 JNK CaMK Casein Kinase

Research Areas:  

Neurological Disease

LRRK2/JNK3-IN-1 is a brain-penetrant multi-target inhibitor of LRRK2 (including G2019S mutant and wild-type) and JNK3, with enzymatic IC50 values of 3.90 nM against LRRK2 G2019S, 3.24 nM against wild-type LRRK2, and 22.1 nM against JNK3. LRRK2/JNK3-IN-1 displays favorable selectivity in a 97-kinase profiling screen, and also shows inhibitory activity against JNK1, JNK2, and MKNK2. LRRK2/JNK3-IN-1 can be used for the research of Parkinson's disease .
loading...
    loading...